MassMEDIC Women in MedTech Virtual Networking & Leadership Forum

Description

Join us on February 18th at 9am EST for a conversation with two extraordinary women VC's and breakout networking. 

Agenda:

• 9:00 Welcome Remarks 
• 9:10 Discussion 
  • Holly Scott, Vice President & Partner, The Mullings Group (moderator) 
  • Michal Geva, Managing Partner and Co-Founder, Triventures 
  • Maria Berkman, Head of the MedTech, Broadview Ventures 
• 10:00 Breakout Networking 
• 10:30 Conclusion

REGISTER HERE

Speakers: 

Michal Geva has 25 years of executive management experience in medtech and digital health startups in Israel and the US at companies such as GI View, TriReme and Bypass and others.  

Over ten years ago, Michal identified that it is not sufficient for a startup to have only a strong, innovative core technology, but in order to realize success in leading markets, it is crucial to have a deep understanding of commercial integration into healthcare systems. With this principle in mind, she co- founded Triventures and became the first woman to found and manage a venture capital fund in Israel.

In 2017, Michal was recognized as one of the 50 most influential women in Israel by Globes, Israel’s leading financial journal and in 2011 she was recognized as one of the 40 most promising leaders in Israel under 40 years old by The Marker, Israel’s leading business journal.

Michal manages the fund, is involved in all major decisions, leads investments and serves as an active board member in the majority of the portfolio companies.

Michal currently participates on the boards of: Bioprotect, Cathworks, Colospan, EyeYon, EarlySense, GlassesUSA, Medisafe, Tailormed and Vi.

Past Triventures’ portfolio companies where Michal participated on the boards include: 6over6, Apica, MST and Orthospace.

Maria Berkman, MD, MBA, is a Director, and Head of the MedTech practice at Broadview Ventures.

Maria shares responsibility for all aspects of Broadview’s investment activity, from identification and screening of new opportunities, through due diligence, negotiation of deal structure, and portfolio company board involvement.

Prior to joining Broadview Ventures, Maria was a management consultant at Monitor Group, where she specialized in life sciences with a focus on corporate, franchise, and asset-level commercial strategy and competitive strategic planning for BioPharma and MedTech clients. Prior to joining Monitor Group, Maria trained within the Partners HealthCare System at Newton Wellesley Hospital in General Surgery. Maria earned an MD from the UCLA School of Medicine, graduating Alpha Omega Alpha with a research focus in cardiothoracic and trauma surgery, and earned an MBA from the Anderson School of Management at UCLA.

Maria currently serves on the boards of Alleviant, Adient, Aria CV, AtaCor, FineHeart, Vascular Graft Solutions and Vectorious, and previously served on the boards of Lyra Therapeutics (NSDQ:LYRA), Apama (acquired), Remedy (acquired), and Capricor (NASDAQ:CAPR).

In addition to her role at Broadview Ventures, Maria contributes time as a SBIR/STTR grant reviewer for the National Science Foundation and is a Strategic Advisory Board Member for the RAD BioMed Accelerator in Tel Aviv, Israel.